RedCo II Master Fund, L.P.
SEC CIK 1921783 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | 10% | 15.57M | $2.25M | $52.5K | 5 | 2024-07-01 | 2024-12-04 |
Most active insiders at ADCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Redmile Group, LLC | 10% | — | $19.64M |
| 2 | Kallebo Lisa Michelle | CAO | — | — |
| 3 | Hug Peter | Dir | — | — |
| 4 | Zaki Mohamed | Chief Medical Off | — | — |
| 5 | MALLIK AMEET | CEO, Dir | — | — |
| 6 | Monges Viviane | Dir | — | — |
| 7 | Carmona Jose | CFO | — | — |
| 8 | Azelby Robert | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | Sandor Victor | Dir | — | — |
RedCo II Master Fund, L.P. made no open-market trades at ADCT in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-12-06 | 2024-12-04 | ADCT | ADC Therapeutics SA | RedCo II Master Fund, L.P. | 10% | S - Sale | $2.07 | -25.4K | 15.57M | -0.2% | -$52.5K |
| DMI | 2024-12-06 | 2024-12-04 | ADCT | ADC Therapeutics SA | RedCo II Master Fund, L.P. | 10% | J - Other | $2.07 | 0 | 15.52M | New | $0 |
| D | 2024-12-06 | 2024-12-04 | ADCT | ADC Therapeutics SA | RedCo II Master Fund, L.P. | 10% | J - Other | $2.07 | +50.7K | 13.05M | +0.4% | +$104.9K |
| 2024-07-03 | 2024-07-01 | ADCT | ADC Therapeutics SA | RedCo II Master Fund, L.P. | 10% | P - Purchase | $2.81 | +400.0K | 13.00M | +3% | +$1.12M | |
| I | 2024-07-03 | 2024-07-01 | ADCT | ADC Therapeutics SA | RedCo II Master Fund, L.P. | 10% | P - Purchase | $2.81 | +400.0K | 15.67M | +3% | +$1.12M |
Purchase Sale Sale after option exercise All abbreviations